nodes	percent_of_prediction	percent_of_DWPC	metapath
Docetaxel—Microtubule Inhibition—Cabazitaxel—prostate cancer	0.265	1	CiPCiCtD
Docetaxel—Cabazitaxel—prostate cancer	0.247	1	CrCtD
Docetaxel—Paclitaxel—Cabazitaxel—prostate cancer	0.144	1	CrCrCtD
Docetaxel—BCL2—prostate cancer	0.0299	0.319	CbGaD
Docetaxel—MAP2—Estramustine—prostate cancer	0.0282	0.171	CbGbCtD
Docetaxel—CYP1B1—prostate cancer	0.0207	0.221	CbGaD
Docetaxel—EGFR—prostate cancer	0.0196	0.208	CbGaD
Docetaxel—CYP3A5—prostate cancer	0.0165	0.176	CbGaD
Docetaxel—TUBB2B—Cabazitaxel—prostate cancer	0.00848	0.0514	CbGbCtD
Docetaxel—TUBB3—Cabazitaxel—prostate cancer	0.00848	0.0514	CbGbCtD
Docetaxel—TUBB6—Cabazitaxel—prostate cancer	0.00848	0.0514	CbGbCtD
Docetaxel—TUBB8—Cabazitaxel—prostate cancer	0.00848	0.0514	CbGbCtD
Docetaxel—TUBB4A—Cabazitaxel—prostate cancer	0.00848	0.0514	CbGbCtD
Docetaxel—TUBB2A—Cabazitaxel—prostate cancer	0.00848	0.0514	CbGbCtD
Docetaxel—CYP3A4—prostate cancer	0.00715	0.0762	CbGaD
Docetaxel—TUBB—Cabazitaxel—prostate cancer	0.00709	0.043	CbGbCtD
Docetaxel—TUBB1—Cabazitaxel—prostate cancer	0.00709	0.043	CbGbCtD
Docetaxel—TUBB4B—Cabazitaxel—prostate cancer	0.00709	0.043	CbGbCtD
Docetaxel—NR1I2—Ethinyl Estradiol—prostate cancer	0.00672	0.0407	CbGbCtD
Docetaxel—NR1I2—Estradiol—prostate cancer	0.00433	0.0262	CbGbCtD
Docetaxel—CYP1B1—Flutamide—prostate cancer	0.00398	0.0241	CbGbCtD
Docetaxel—ABCC10—Estradiol—prostate cancer	0.00304	0.0184	CbGbCtD
Docetaxel—SLCO1B3—Cabazitaxel—prostate cancer	0.00303	0.0183	CbGbCtD
Docetaxel—CYP1B1—Estrone—prostate cancer	0.00288	0.0174	CbGbCtD
Docetaxel—ABCC1—Abiraterone—prostate cancer	0.00283	0.0171	CbGbCtD
Docetaxel—ABCC10—Etoposide—prostate cancer	0.00199	0.012	CbGbCtD
Docetaxel—SLCO1B3—Conjugated Estrogens—prostate cancer	0.00194	0.0117	CbGbCtD
Docetaxel—CYP1B1—Mitoxantrone—prostate cancer	0.00171	0.0104	CbGbCtD
Docetaxel—SLCO1B3—Estradiol—prostate cancer	0.0017	0.0103	CbGbCtD
Docetaxel—CYP1B1—Estradiol—prostate cancer	0.00165	0.01	CbGbCtD
Docetaxel—ABCG2—Cabazitaxel—prostate cancer	0.0014	0.00848	CbGbCtD
Docetaxel—ABCG2—Estrone—prostate cancer	0.00137	0.00829	CbGbCtD
Docetaxel—ABCC10—Doxorubicin—prostate cancer	0.00136	0.00821	CbGbCtD
Docetaxel—ABCC2—Ethinyl Estradiol—prostate cancer	0.00135	0.00817	CbGbCtD
Docetaxel—ABCC1—Conjugated Estrogens—prostate cancer	0.00134	0.00811	CbGbCtD
Docetaxel—ABCC1—Mitoxantrone—prostate cancer	0.00122	0.00737	CbGbCtD
Docetaxel—CYP3A5—Flutamide—prostate cancer	0.00105	0.00635	CbGbCtD
Docetaxel—ABCC2—Conjugated Estrogens—prostate cancer	0.00099	0.006	CbGbCtD
Docetaxel—ABCC1—Epirubicin—prostate cancer	0.000985	0.00596	CbGbCtD
Docetaxel—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.00094	0.00569	CbGbCtD
Docetaxel—ABCG2—Conjugated Estrogens—prostate cancer	0.000895	0.00542	CbGbCtD
Docetaxel—ABCG2—Mitoxantrone—prostate cancer	0.000814	0.00493	CbGbCtD
Docetaxel—ABCG2—Estradiol—prostate cancer	0.000786	0.00476	CbGbCtD
Docetaxel—CYP3A5—Cabazitaxel—prostate cancer	0.000776	0.0047	CbGbCtD
Docetaxel—ABCC1—Etoposide—prostate cancer	0.000767	0.00465	CbGbCtD
Docetaxel—ABCB1—Estramustine—prostate cancer	0.000766	0.00464	CbGbCtD
Docetaxel—CYP3A5—Estrone—prostate cancer	0.000758	0.00459	CbGbCtD
Docetaxel—CYP1B1—Doxorubicin—prostate cancer	0.000737	0.00446	CbGbCtD
Docetaxel—CYP3A7-CYP3A51P—Estradiol—prostate cancer	0.000581	0.00352	CbGbCtD
Docetaxel—CYP3A7—Estradiol—prostate cancer	0.000581	0.00352	CbGbCtD
Docetaxel—ABCC2—Etoposide—prostate cancer	0.000568	0.00344	CbGbCtD
Docetaxel—ABCC1—Doxorubicin—prostate cancer	0.000523	0.00317	CbGbCtD
Docetaxel—ABCG2—Etoposide—prostate cancer	0.000513	0.00311	CbGbCtD
Docetaxel—ABCB1—Cabazitaxel—prostate cancer	0.000505	0.00306	CbGbCtD
Docetaxel—CYP3A4—Bicalutamide—prostate cancer	0.000494	0.00299	CbGbCtD
Docetaxel—ABCB1—Estrone—prostate cancer	0.000494	0.00299	CbGbCtD
Docetaxel—CYP3A4—Estramustine—prostate cancer	0.000459	0.00278	CbGbCtD
Docetaxel—ABCB1—Ethinyl Estradiol—prostate cancer	0.00044	0.00266	CbGbCtD
Docetaxel—CYP3A5—Estradiol—prostate cancer	0.000436	0.00264	CbGbCtD
Docetaxel—MAPT—prostate gland—prostate cancer	0.000428	0.0328	CbGeAlD
Docetaxel—CYP3A4—Abiraterone—prostate cancer	0.000409	0.00248	CbGbCtD
Docetaxel—CYP3A4—Flutamide—prostate cancer	0.000409	0.00248	CbGbCtD
Docetaxel—ABCC2—Doxorubicin—prostate cancer	0.000387	0.00235	CbGbCtD
Docetaxel—KIF11—bone marrow—prostate cancer	0.000376	0.0289	CbGeAlD
Docetaxel—ABCG2—Doxorubicin—prostate cancer	0.00035	0.00212	CbGbCtD
Docetaxel—MAP4—prostate gland—prostate cancer	0.000337	0.0258	CbGeAlD
Docetaxel—ABCB1—Conjugated Estrogens—prostate cancer	0.000323	0.00196	CbGbCtD
Docetaxel—KIF11—testis—prostate cancer	0.000322	0.0247	CbGeAlD
Docetaxel—BCL2—prostate gland—prostate cancer	0.000306	0.0235	CbGeAlD
Docetaxel—CYP3A4—Cabazitaxel—prostate cancer	0.000303	0.00183	CbGbCtD
Docetaxel—EGFR—prostate gland—prostate cancer	0.000302	0.0232	CbGeAlD
Docetaxel—CYP3A4—Estrone—prostate cancer	0.000296	0.00179	CbGbCtD
Docetaxel—ABCB1—Mitoxantrone—prostate cancer	0.000294	0.00178	CbGbCtD
Docetaxel—CYP3A5—Etoposide—prostate cancer	0.000284	0.00172	CbGbCtD
Docetaxel—ABCB1—Estradiol—prostate cancer	0.000283	0.00172	CbGbCtD
Docetaxel—MAP2—prostate gland—prostate cancer	0.000265	0.0203	CbGeAlD
Docetaxel—CYP3A4—Ethinyl Estradiol—prostate cancer	0.000264	0.0016	CbGbCtD
Docetaxel—ABCB1—Prednisone—prostate cancer	0.000244	0.00148	CbGbCtD
Docetaxel—KIF11—lymph node—prostate cancer	0.000233	0.0179	CbGeAlD
Docetaxel—MAP4—renal system—prostate cancer	0.000229	0.0176	CbGeAlD
Docetaxel—BCL2—epithelium—prostate cancer	0.000225	0.0172	CbGeAlD
Docetaxel—MAP2—seminal vesicle—prostate cancer	0.000224	0.0172	CbGeAlD
Docetaxel—TUBB8—testis—prostate cancer	0.000217	0.0167	CbGeAlD
Docetaxel—BCL2—renal system—prostate cancer	0.000209	0.016	CbGeAlD
Docetaxel—TUBB4A—prostate gland—prostate cancer	0.000205	0.0157	CbGeAlD
Docetaxel—TUBB2B—prostate gland—prostate cancer	0.000198	0.0152	CbGeAlD
Docetaxel—CYP3A4—Conjugated Estrogens—prostate cancer	0.000193	0.00117	CbGbCtD
Docetaxel—MAPT—testis—prostate cancer	0.000189	0.0145	CbGeAlD
Docetaxel—TUBB—prostate gland—prostate cancer	0.000187	0.0144	CbGeAlD
Docetaxel—TUBB2A—prostate gland—prostate cancer	0.000186	0.0143	CbGeAlD
Docetaxel—ABCB1—Etoposide—prostate cancer	0.000185	0.00112	CbGbCtD
Docetaxel—TUBB6—prostate gland—prostate cancer	0.000184	0.0141	CbGeAlD
Docetaxel—CYP3A4—urine—prostate cancer	0.000183	0.014	CbGeAlD
Docetaxel—Paclitaxel—BCL2—prostate cancer	0.000182	0.252	CrCbGaD
Docetaxel—MAP2—urethra—prostate cancer	0.000177	0.0136	CbGeAlD
Docetaxel—CYP3A4—Mitoxantrone—prostate cancer	0.000176	0.00107	CbGbCtD
Docetaxel—CYP3A4—Estradiol—prostate cancer	0.00017	0.00103	CbGbCtD
Docetaxel—KIF11—Fulvestrant—Estradiol—prostate cancer	0.00017	0.306	CbGdCrCtD
Docetaxel—TUBB1—bone marrow—prostate cancer	0.00017	0.013	CbGeAlD
Docetaxel—TUBB2B—seminal vesicle—prostate cancer	0.000167	0.0128	CbGeAlD
Docetaxel—ABCC10—prostate gland—prostate cancer	0.000161	0.0123	CbGeAlD
Docetaxel—TUBB4B—prostate gland—prostate cancer	0.00016	0.0123	CbGeAlD
Docetaxel—TUBB—seminal vesicle—prostate cancer	0.000158	0.0122	CbGeAlD
Docetaxel—BCL2—bone marrow—prostate cancer	0.000158	0.0121	CbGeAlD
Docetaxel—TUBB2A—seminal vesicle—prostate cancer	0.000158	0.0121	CbGeAlD
Docetaxel—SLC22A7—renal system—prostate cancer	0.000156	0.012	CbGeAlD
Docetaxel—TUBB6—seminal vesicle—prostate cancer	0.000155	0.0119	CbGeAlD
Docetaxel—KIF11—Teniposide—Etoposide—prostate cancer	0.000149	0.27	CbGdCrCtD
Docetaxel—TUBB3—testis—prostate cancer	0.000148	0.0114	CbGeAlD
Docetaxel—MAP4—testis—prostate cancer	0.000148	0.0114	CbGeAlD
Docetaxel—CYP3A4—Prednisone—prostate cancer	0.000146	0.000885	CbGbCtD
Docetaxel—TUBB1—testis—prostate cancer	0.000145	0.0111	CbGeAlD
Docetaxel—TUBB4A—renal system—prostate cancer	0.00014	0.0107	CbGeAlD
Docetaxel—MAPT—lymph node—prostate cancer	0.000137	0.0105	CbGeAlD
Docetaxel—ABCC10—seminal vesicle—prostate cancer	0.000136	0.0104	CbGeAlD
Docetaxel—TUBB4B—seminal vesicle—prostate cancer	0.000135	0.0104	CbGeAlD
Docetaxel—TUBB6—epithelium—prostate cancer	0.000135	0.0104	CbGeAlD
Docetaxel—TUBB2B—renal system—prostate cancer	0.000135	0.0104	CbGeAlD
Docetaxel—BCL2—testis—prostate cancer	0.000135	0.0103	CbGeAlD
Docetaxel—EGFR—testis—prostate cancer	0.000133	0.0102	CbGeAlD
Docetaxel—TUBB2B—urethra—prostate cancer	0.000133	0.0102	CbGeAlD
Docetaxel—ABCC2—prostate gland—prostate cancer	0.000129	0.00991	CbGeAlD
Docetaxel—CYP1B1—prostate gland—prostate cancer	0.000127	0.00971	CbGeAlD
Docetaxel—Paclitaxel—CYP1B1—prostate cancer	0.000126	0.175	CrCbGaD
Docetaxel—ABCB1—Doxorubicin—prostate cancer	0.000126	0.000765	CbGbCtD
Docetaxel—TUBB—urethra—prostate cancer	0.000125	0.00962	CbGeAlD
Docetaxel—TUBB6—renal system—prostate cancer	0.000125	0.00961	CbGeAlD
Docetaxel—TUBB2A—urethra—prostate cancer	0.000125	0.00957	CbGeAlD
Docetaxel—Cabazitaxel—CYP3A5—prostate cancer	0.000125	0.172	CrCbGaD
Docetaxel—TUBB6—urethra—prostate cancer	0.000123	0.00944	CbGeAlD
Docetaxel—BCL2—Fulvestrant—Estradiol—prostate cancer	0.000123	0.221	CbGdCrCtD
Docetaxel—MAP2—testis—prostate cancer	0.000117	0.00896	CbGeAlD
Docetaxel—ABCC1—prostate gland—prostate cancer	0.000114	0.00873	CbGeAlD
Docetaxel—CYP3A4—Etoposide—prostate cancer	0.000111	0.000672	CbGbCtD
Docetaxel—ABCC10—renal system—prostate cancer	0.00011	0.00841	CbGeAlD
Docetaxel—TUBB4B—renal system—prostate cancer	0.000109	0.00835	CbGeAlD
Docetaxel—ABCC10—urethra—prostate cancer	0.000108	0.00827	CbGeAlD
Docetaxel—MAP4—lymph node—prostate cancer	0.000107	0.00825	CbGeAlD
Docetaxel—TUBB4B—urethra—prostate cancer	0.000107	0.00821	CbGeAlD
Docetaxel—SLC22A7—testis—prostate cancer	0.000101	0.00774	CbGeAlD
Docetaxel—Paclitaxel—CYP3A5—prostate cancer	0.000101	0.139	CrCbGaD
Docetaxel—BCL2—lymph node—prostate cancer	9.77e-05	0.0075	CbGeAlD
Docetaxel—EGFR—lymph node—prostate cancer	9.65e-05	0.00741	CbGeAlD
Docetaxel—TUBB—bone marrow—prostate cancer	9.65e-05	0.00741	CbGeAlD
Docetaxel—ABCC1—seminal vesicle—prostate cancer	9.63e-05	0.00739	CbGeAlD
Docetaxel—TUBB2A—bone marrow—prostate cancer	9.6e-05	0.00737	CbGeAlD
Docetaxel—TUBB6—bone marrow—prostate cancer	9.47e-05	0.00727	CbGeAlD
Docetaxel—ABCG2—prostate gland—prostate cancer	9.42e-05	0.00723	CbGeAlD
Docetaxel—Paclitaxel—CYP19A1—prostate cancer	9.27e-05	0.128	CrCbGaD
Docetaxel—TUBB4A—testis—prostate cancer	9.02e-05	0.00692	CbGeAlD
Docetaxel—ABCC2—renal system—prostate cancer	8.81e-05	0.00676	CbGeAlD
Docetaxel—CYP3A5—prostate gland—prostate cancer	8.75e-05	0.00671	CbGeAlD
Docetaxel—TUBB2B—testis—prostate cancer	8.72e-05	0.00669	CbGeAlD
Docetaxel—CYP1B1—renal system—prostate cancer	8.63e-05	0.00662	CbGeAlD
Docetaxel—MAP2—lymph node—prostate cancer	8.46e-05	0.00649	CbGeAlD
Docetaxel—ABCC10—bone marrow—prostate cancer	8.29e-05	0.00636	CbGeAlD
Docetaxel—TUBB—testis—prostate cancer	8.25e-05	0.00633	CbGeAlD
Docetaxel—TUBB4B—bone marrow—prostate cancer	8.23e-05	0.00632	CbGeAlD
Docetaxel—TUBB2A—testis—prostate cancer	8.21e-05	0.0063	CbGeAlD
Docetaxel—TUBB6—testis—prostate cancer	8.1e-05	0.00621	CbGeAlD
Docetaxel—ABCG2—seminal vesicle—prostate cancer	7.97e-05	0.00611	CbGeAlD
Docetaxel—ABCC1—urethra—prostate cancer	7.62e-05	0.00585	CbGeAlD
Docetaxel—CYP3A4—Doxorubicin—prostate cancer	7.56e-05	0.000458	CbGbCtD
Docetaxel—ABCC10—testis—prostate cancer	7.09e-05	0.00544	CbGeAlD
Docetaxel—TUBB4B—testis—prostate cancer	7.04e-05	0.0054	CbGeAlD
Docetaxel—TUBB4A—lymph node—prostate cancer	6.54e-05	0.00502	CbGeAlD
Docetaxel—TUBB2B—lymph node—prostate cancer	6.32e-05	0.00485	CbGeAlD
Docetaxel—ABCG2—urethra—prostate cancer	6.31e-05	0.00484	CbGeAlD
Docetaxel—TUBB—lymph node—prostate cancer	5.98e-05	0.00459	CbGeAlD
Docetaxel—CYP3A5—renal system—prostate cancer	5.96e-05	0.00457	CbGeAlD
Docetaxel—TUBB2A—lymph node—prostate cancer	5.95e-05	0.00457	CbGeAlD
Docetaxel—TUBB6—lymph node—prostate cancer	5.87e-05	0.0045	CbGeAlD
Docetaxel—ABCC2—testis—prostate cancer	5.69e-05	0.00437	CbGeAlD
Docetaxel—CYP1B1—testis—prostate cancer	5.57e-05	0.00428	CbGeAlD
Docetaxel—Cabazitaxel—CYP3A4—prostate cancer	5.39e-05	0.0745	CrCbGaD
Docetaxel—ABCC10—lymph node—prostate cancer	5.14e-05	0.00394	CbGeAlD
Docetaxel—TUBB4B—lymph node—prostate cancer	5.1e-05	0.00391	CbGeAlD
Docetaxel—ABCC1—testis—prostate cancer	5.01e-05	0.00385	CbGeAlD
Docetaxel—ABCG2—bone marrow—prostate cancer	4.86e-05	0.00373	CbGeAlD
Docetaxel—ABCB1—prostate gland—prostate cancer	4.65e-05	0.00356	CbGeAlD
Docetaxel—CYP3A4—renal system—prostate cancer	4.47e-05	0.00343	CbGeAlD
Docetaxel—TUBB6—Fulvestrant—Estradiol—prostate cancer	4.44e-05	0.0802	CbGdCrCtD
Docetaxel—Paclitaxel—CYP3A4—prostate cancer	4.36e-05	0.0602	CrCbGaD
Docetaxel—ABCG2—testis—prostate cancer	4.15e-05	0.00318	CbGeAlD
Docetaxel—ABCC2—lymph node—prostate cancer	4.13e-05	0.00317	CbGeAlD
Docetaxel—CYP1B1—lymph node—prostate cancer	4.04e-05	0.0031	CbGeAlD
Docetaxel—ABCB1—seminal vesicle—prostate cancer	3.93e-05	0.00302	CbGeAlD
Docetaxel—TUBB6—Levorphanol—Estrone—prostate cancer	3.87e-05	0.0699	CbGdCrCtD
Docetaxel—ABCC1—lymph node—prostate cancer	3.63e-05	0.00279	CbGeAlD
Docetaxel—ABCB1—epithelium—prostate cancer	3.41e-05	0.00262	CbGeAlD
Docetaxel—ABCB1—renal system—prostate cancer	3.17e-05	0.00243	CbGeAlD
Docetaxel—ABCB1—urethra—prostate cancer	3.11e-05	0.00239	CbGeAlD
Docetaxel—ABCG2—lymph node—prostate cancer	3.01e-05	0.00231	CbGeAlD
Docetaxel—TUBB6—Levorphanol—Estradiol—prostate cancer	2.94e-05	0.053	CbGdCrCtD
Docetaxel—ABCB1—bone marrow—prostate cancer	2.39e-05	0.00184	CbGeAlD
Docetaxel—ABCB1—testis—prostate cancer	2.05e-05	0.00157	CbGeAlD
Docetaxel—ABCB1—lymph node—prostate cancer	1.48e-05	0.00114	CbGeAlD
Docetaxel—Confusional state—Capecitabine—prostate cancer	5.44e-06	0.000135	CcSEcCtD
Docetaxel—Headache—Estradiol—prostate cancer	5.42e-06	0.000135	CcSEcCtD
Docetaxel—Stevens-Johnson syndrome—Doxorubicin—prostate cancer	5.4e-06	0.000135	CcSEcCtD
Docetaxel—Oedema—Capecitabine—prostate cancer	5.39e-06	0.000134	CcSEcCtD
Docetaxel—Renal failure—Doxorubicin—prostate cancer	5.36e-06	0.000133	CcSEcCtD
Docetaxel—Infection—Capecitabine—prostate cancer	5.36e-06	0.000133	CcSEcCtD
Docetaxel—Neuropathy peripheral—Doxorubicin—prostate cancer	5.34e-06	0.000133	CcSEcCtD
Docetaxel—Haemoglobin—Epirubicin—prostate cancer	5.31e-06	0.000132	CcSEcCtD
Docetaxel—Stomatitis—Doxorubicin—prostate cancer	5.31e-06	0.000132	CcSEcCtD
Docetaxel—Jaundice—Doxorubicin—prostate cancer	5.31e-06	0.000132	CcSEcCtD
Docetaxel—Shock—Capecitabine—prostate cancer	5.3e-06	0.000132	CcSEcCtD
Docetaxel—Rhinitis—Epirubicin—prostate cancer	5.3e-06	0.000132	CcSEcCtD
Docetaxel—Abdominal pain—Etoposide—prostate cancer	5.3e-06	0.000132	CcSEcCtD
Docetaxel—Body temperature increased—Etoposide—prostate cancer	5.3e-06	0.000132	CcSEcCtD
Docetaxel—Conjunctivitis—Doxorubicin—prostate cancer	5.3e-06	0.000132	CcSEcCtD
Docetaxel—Nervous system disorder—Capecitabine—prostate cancer	5.29e-06	0.000132	CcSEcCtD
Docetaxel—Haemorrhage—Epirubicin—prostate cancer	5.29e-06	0.000132	CcSEcCtD
Docetaxel—Hepatitis—Epirubicin—prostate cancer	5.29e-06	0.000132	CcSEcCtD
Docetaxel—Thrombocytopenia—Capecitabine—prostate cancer	5.28e-06	0.000132	CcSEcCtD
Docetaxel—Syncope—Prednisone—prostate cancer	5.28e-06	0.000131	CcSEcCtD
Docetaxel—Tachycardia—Capecitabine—prostate cancer	5.26e-06	0.000131	CcSEcCtD
Docetaxel—Hypoaesthesia—Epirubicin—prostate cancer	5.26e-06	0.000131	CcSEcCtD
Docetaxel—Pharyngitis—Epirubicin—prostate cancer	5.25e-06	0.000131	CcSEcCtD
Docetaxel—Skin disorder—Capecitabine—prostate cancer	5.24e-06	0.00013	CcSEcCtD
Docetaxel—Urinary tract disorder—Epirubicin—prostate cancer	5.22e-06	0.00013	CcSEcCtD
Docetaxel—Oedema peripheral—Epirubicin—prostate cancer	5.21e-06	0.00013	CcSEcCtD
Docetaxel—Connective tissue disorder—Epirubicin—prostate cancer	5.19e-06	0.000129	CcSEcCtD
Docetaxel—Urethral disorder—Epirubicin—prostate cancer	5.18e-06	0.000129	CcSEcCtD
Docetaxel—Loss of consciousness—Prednisone—prostate cancer	5.17e-06	0.000129	CcSEcCtD
Docetaxel—Hepatobiliary disease—Doxorubicin—prostate cancer	5.15e-06	0.000128	CcSEcCtD
Docetaxel—Epistaxis—Doxorubicin—prostate cancer	5.14e-06	0.000128	CcSEcCtD
Docetaxel—Anorexia—Capecitabine—prostate cancer	5.14e-06	0.000128	CcSEcCtD
Docetaxel—Nausea—Estradiol—prostate cancer	5.13e-06	0.000128	CcSEcCtD
Docetaxel—Vomiting—Mitoxantrone—prostate cancer	5.12e-06	0.000128	CcSEcCtD
Docetaxel—Convulsion—Prednisone—prostate cancer	5.1e-06	0.000127	CcSEcCtD
Docetaxel—Visual impairment—Epirubicin—prostate cancer	5.09e-06	0.000127	CcSEcCtD
Docetaxel—Agranulocytosis—Doxorubicin—prostate cancer	5.08e-06	0.000127	CcSEcCtD
Docetaxel—Hypertension—Prednisone—prostate cancer	5.08e-06	0.000127	CcSEcCtD
Docetaxel—Rash—Mitoxantrone—prostate cancer	5.08e-06	0.000127	CcSEcCtD
Docetaxel—Dermatitis—Mitoxantrone—prostate cancer	5.07e-06	0.000126	CcSEcCtD
Docetaxel—Headache—Mitoxantrone—prostate cancer	5.05e-06	0.000126	CcSEcCtD
Docetaxel—Hypotension—Capecitabine—prostate cancer	5.04e-06	0.000126	CcSEcCtD
Docetaxel—Arthralgia—Prednisone—prostate cancer	5.01e-06	0.000125	CcSEcCtD
Docetaxel—Myalgia—Prednisone—prostate cancer	5.01e-06	0.000125	CcSEcCtD
Docetaxel—Erythema multiforme—Epirubicin—prostate cancer	5e-06	0.000125	CcSEcCtD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	4.97e-06	0.000124	CcSEcCtD
Docetaxel—Eye disorder—Epirubicin—prostate cancer	4.94e-06	0.000123	CcSEcCtD
Docetaxel—Hypersensitivity—Etoposide—prostate cancer	4.94e-06	0.000123	CcSEcCtD
Docetaxel—Haemoglobin—Doxorubicin—prostate cancer	4.92e-06	0.000123	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Capecitabine—prostate cancer	4.91e-06	0.000122	CcSEcCtD
Docetaxel—Cardiac disorder—Epirubicin—prostate cancer	4.91e-06	0.000122	CcSEcCtD
Docetaxel—Flushing—Epirubicin—prostate cancer	4.91e-06	0.000122	CcSEcCtD
Docetaxel—Rhinitis—Doxorubicin—prostate cancer	4.9e-06	0.000122	CcSEcCtD
Docetaxel—Hepatitis—Doxorubicin—prostate cancer	4.89e-06	0.000122	CcSEcCtD
Docetaxel—Haemorrhage—Doxorubicin—prostate cancer	4.89e-06	0.000122	CcSEcCtD
Docetaxel—Insomnia—Capecitabine—prostate cancer	4.88e-06	0.000121	CcSEcCtD
Docetaxel—Hypoaesthesia—Doxorubicin—prostate cancer	4.87e-06	0.000121	CcSEcCtD
Docetaxel—Pharyngitis—Doxorubicin—prostate cancer	4.85e-06	0.000121	CcSEcCtD
Docetaxel—Paraesthesia—Capecitabine—prostate cancer	4.84e-06	0.000121	CcSEcCtD
Docetaxel—Urinary tract disorder—Doxorubicin—prostate cancer	4.83e-06	0.00012	CcSEcCtD
Docetaxel—Oedema peripheral—Doxorubicin—prostate cancer	4.82e-06	0.00012	CcSEcCtD
Docetaxel—Asthenia—Etoposide—prostate cancer	4.81e-06	0.00012	CcSEcCtD
Docetaxel—Connective tissue disorder—Doxorubicin—prostate cancer	4.81e-06	0.00012	CcSEcCtD
Docetaxel—Dyspnoea—Capecitabine—prostate cancer	4.81e-06	0.00012	CcSEcCtD
Docetaxel—Anaphylactic shock—Prednisone—prostate cancer	4.8e-06	0.00012	CcSEcCtD
Docetaxel—Oedema—Prednisone—prostate cancer	4.8e-06	0.00012	CcSEcCtD
Docetaxel—Angiopathy—Epirubicin—prostate cancer	4.8e-06	0.00012	CcSEcCtD
Docetaxel—Urethral disorder—Doxorubicin—prostate cancer	4.79e-06	0.000119	CcSEcCtD
Docetaxel—Nausea—Mitoxantrone—prostate cancer	4.78e-06	0.000119	CcSEcCtD
Docetaxel—Immune system disorder—Epirubicin—prostate cancer	4.77e-06	0.000119	CcSEcCtD
Docetaxel—Infection—Prednisone—prostate cancer	4.77e-06	0.000119	CcSEcCtD
Docetaxel—Mediastinal disorder—Epirubicin—prostate cancer	4.76e-06	0.000119	CcSEcCtD
Docetaxel—Dyspepsia—Capecitabine—prostate cancer	4.75e-06	0.000118	CcSEcCtD
Docetaxel—Chills—Epirubicin—prostate cancer	4.74e-06	0.000118	CcSEcCtD
Docetaxel—Pruritus—Etoposide—prostate cancer	4.74e-06	0.000118	CcSEcCtD
Docetaxel—Shock—Prednisone—prostate cancer	4.72e-06	0.000118	CcSEcCtD
Docetaxel—Arrhythmia—Epirubicin—prostate cancer	4.72e-06	0.000118	CcSEcCtD
Docetaxel—Visual impairment—Doxorubicin—prostate cancer	4.71e-06	0.000117	CcSEcCtD
Docetaxel—Nervous system disorder—Prednisone—prostate cancer	4.71e-06	0.000117	CcSEcCtD
Docetaxel—Tachycardia—Prednisone—prostate cancer	4.69e-06	0.000117	CcSEcCtD
Docetaxel—Decreased appetite—Capecitabine—prostate cancer	4.69e-06	0.000117	CcSEcCtD
Docetaxel—Alopecia—Epirubicin—prostate cancer	4.67e-06	0.000116	CcSEcCtD
Docetaxel—Skin disorder—Prednisone—prostate cancer	4.66e-06	0.000116	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Capecitabine—prostate cancer	4.65e-06	0.000116	CcSEcCtD
Docetaxel—Fatigue—Capecitabine—prostate cancer	4.65e-06	0.000116	CcSEcCtD
Docetaxel—Mental disorder—Epirubicin—prostate cancer	4.63e-06	0.000115	CcSEcCtD
Docetaxel—Erythema multiforme—Doxorubicin—prostate cancer	4.62e-06	0.000115	CcSEcCtD
Docetaxel—Pain—Capecitabine—prostate cancer	4.61e-06	0.000115	CcSEcCtD
Docetaxel—Constipation—Capecitabine—prostate cancer	4.61e-06	0.000115	CcSEcCtD
Docetaxel—Erythema—Epirubicin—prostate cancer	4.6e-06	0.000115	CcSEcCtD
Docetaxel—Malnutrition—Epirubicin—prostate cancer	4.6e-06	0.000115	CcSEcCtD
Docetaxel—Diarrhoea—Etoposide—prostate cancer	4.58e-06	0.000114	CcSEcCtD
Docetaxel—Anorexia—Prednisone—prostate cancer	4.58e-06	0.000114	CcSEcCtD
Docetaxel—Eye disorder—Doxorubicin—prostate cancer	4.57e-06	0.000114	CcSEcCtD
Docetaxel—Cardiac disorder—Doxorubicin—prostate cancer	4.54e-06	0.000113	CcSEcCtD
Docetaxel—Flushing—Doxorubicin—prostate cancer	4.54e-06	0.000113	CcSEcCtD
Docetaxel—Dysgeusia—Epirubicin—prostate cancer	4.51e-06	0.000112	CcSEcCtD
Docetaxel—Back pain—Epirubicin—prostate cancer	4.45e-06	0.000111	CcSEcCtD
Docetaxel—Feeling abnormal—Capecitabine—prostate cancer	4.44e-06	0.000111	CcSEcCtD
Docetaxel—Angiopathy—Doxorubicin—prostate cancer	4.44e-06	0.000111	CcSEcCtD
Docetaxel—Dizziness—Etoposide—prostate cancer	4.43e-06	0.00011	CcSEcCtD
Docetaxel—Muscle spasms—Epirubicin—prostate cancer	4.42e-06	0.00011	CcSEcCtD
Docetaxel—Immune system disorder—Doxorubicin—prostate cancer	4.42e-06	0.00011	CcSEcCtD
Docetaxel—Gastrointestinal pain—Capecitabine—prostate cancer	4.41e-06	0.00011	CcSEcCtD
Docetaxel—Mediastinal disorder—Doxorubicin—prostate cancer	4.41e-06	0.00011	CcSEcCtD
Docetaxel—Chills—Doxorubicin—prostate cancer	4.39e-06	0.000109	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Prednisone—prostate cancer	4.38e-06	0.000109	CcSEcCtD
Docetaxel—Arrhythmia—Doxorubicin—prostate cancer	4.37e-06	0.000109	CcSEcCtD
Docetaxel—Insomnia—Prednisone—prostate cancer	4.34e-06	0.000108	CcSEcCtD
Docetaxel—Alopecia—Doxorubicin—prostate cancer	4.32e-06	0.000108	CcSEcCtD
Docetaxel—Paraesthesia—Prednisone—prostate cancer	4.31e-06	0.000107	CcSEcCtD
Docetaxel—Mental disorder—Doxorubicin—prostate cancer	4.29e-06	0.000107	CcSEcCtD
Docetaxel—Abdominal pain—Capecitabine—prostate cancer	4.26e-06	0.000106	CcSEcCtD
Docetaxel—Body temperature increased—Capecitabine—prostate cancer	4.26e-06	0.000106	CcSEcCtD
Docetaxel—Vomiting—Etoposide—prostate cancer	4.26e-06	0.000106	CcSEcCtD
Docetaxel—Erythema—Doxorubicin—prostate cancer	4.26e-06	0.000106	CcSEcCtD
Docetaxel—Malnutrition—Doxorubicin—prostate cancer	4.26e-06	0.000106	CcSEcCtD
Docetaxel—Anaemia—Epirubicin—prostate cancer	4.25e-06	0.000106	CcSEcCtD
Docetaxel—Dyspepsia—Prednisone—prostate cancer	4.23e-06	0.000105	CcSEcCtD
Docetaxel—Rash—Etoposide—prostate cancer	4.22e-06	0.000105	CcSEcCtD
Docetaxel—Dermatitis—Etoposide—prostate cancer	4.22e-06	0.000105	CcSEcCtD
Docetaxel—Headache—Etoposide—prostate cancer	4.2e-06	0.000105	CcSEcCtD
Docetaxel—Decreased appetite—Prednisone—prostate cancer	4.17e-06	0.000104	CcSEcCtD
Docetaxel—Dysgeusia—Doxorubicin—prostate cancer	4.17e-06	0.000104	CcSEcCtD
Docetaxel—Fatigue—Prednisone—prostate cancer	4.14e-06	0.000103	CcSEcCtD
Docetaxel—Syncope—Epirubicin—prostate cancer	4.13e-06	0.000103	CcSEcCtD
Docetaxel—Leukopenia—Epirubicin—prostate cancer	4.12e-06	0.000103	CcSEcCtD
Docetaxel—Back pain—Doxorubicin—prostate cancer	4.12e-06	0.000103	CcSEcCtD
Docetaxel—Constipation—Prednisone—prostate cancer	4.11e-06	0.000102	CcSEcCtD
Docetaxel—Muscle spasms—Doxorubicin—prostate cancer	4.09e-06	0.000102	CcSEcCtD
Docetaxel—Palpitations—Epirubicin—prostate cancer	4.07e-06	0.000101	CcSEcCtD
Docetaxel—Loss of consciousness—Epirubicin—prostate cancer	4.04e-06	0.000101	CcSEcCtD
Docetaxel—Cough—Epirubicin—prostate cancer	4.02e-06	0.0001	CcSEcCtD
Docetaxel—Convulsion—Epirubicin—prostate cancer	3.99e-06	9.94e-05	CcSEcCtD
Docetaxel—Nausea—Etoposide—prostate cancer	3.98e-06	9.92e-05	CcSEcCtD
Docetaxel—Hypertension—Epirubicin—prostate cancer	3.97e-06	9.9e-05	CcSEcCtD
Docetaxel—Hypersensitivity—Capecitabine—prostate cancer	3.97e-06	9.9e-05	CcSEcCtD
Docetaxel—Feeling abnormal—Prednisone—prostate cancer	3.96e-06	9.86e-05	CcSEcCtD
Docetaxel—Anaemia—Doxorubicin—prostate cancer	3.94e-06	9.81e-05	CcSEcCtD
Docetaxel—Gastrointestinal pain—Prednisone—prostate cancer	3.93e-06	9.78e-05	CcSEcCtD
Docetaxel—Chest pain—Epirubicin—prostate cancer	3.92e-06	9.76e-05	CcSEcCtD
Docetaxel—Arthralgia—Epirubicin—prostate cancer	3.92e-06	9.76e-05	CcSEcCtD
Docetaxel—Myalgia—Epirubicin—prostate cancer	3.92e-06	9.76e-05	CcSEcCtD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	3.89e-06	9.7e-05	CcSEcCtD
Docetaxel—Asthenia—Capecitabine—prostate cancer	3.87e-06	9.64e-05	CcSEcCtD
Docetaxel—Dry mouth—Epirubicin—prostate cancer	3.83e-06	9.55e-05	CcSEcCtD
Docetaxel—Syncope—Doxorubicin—prostate cancer	3.82e-06	9.51e-05	CcSEcCtD
Docetaxel—Pruritus—Capecitabine—prostate cancer	3.81e-06	9.5e-05	CcSEcCtD
Docetaxel—Leukopenia—Doxorubicin—prostate cancer	3.81e-06	9.5e-05	CcSEcCtD
Docetaxel—Body temperature increased—Prednisone—prostate cancer	3.8e-06	9.46e-05	CcSEcCtD
Docetaxel—Abdominal pain—Prednisone—prostate cancer	3.8e-06	9.46e-05	CcSEcCtD
Docetaxel—Confusional state—Epirubicin—prostate cancer	3.79e-06	9.44e-05	CcSEcCtD
Docetaxel—Palpitations—Doxorubicin—prostate cancer	3.76e-06	9.38e-05	CcSEcCtD
Docetaxel—Oedema—Epirubicin—prostate cancer	3.76e-06	9.36e-05	CcSEcCtD
Docetaxel—Anaphylactic shock—Epirubicin—prostate cancer	3.76e-06	9.36e-05	CcSEcCtD
Docetaxel—Loss of consciousness—Doxorubicin—prostate cancer	3.74e-06	9.33e-05	CcSEcCtD
Docetaxel—Infection—Epirubicin—prostate cancer	3.73e-06	9.3e-05	CcSEcCtD
Docetaxel—Cough—Doxorubicin—prostate cancer	3.72e-06	9.26e-05	CcSEcCtD
Docetaxel—Shock—Epirubicin—prostate cancer	3.69e-06	9.21e-05	CcSEcCtD
Docetaxel—Convulsion—Doxorubicin—prostate cancer	3.69e-06	9.19e-05	CcSEcCtD
Docetaxel—Diarrhoea—Capecitabine—prostate cancer	3.69e-06	9.19e-05	CcSEcCtD
Docetaxel—Nervous system disorder—Epirubicin—prostate cancer	3.68e-06	9.18e-05	CcSEcCtD
Docetaxel—Thrombocytopenia—Epirubicin—prostate cancer	3.68e-06	9.16e-05	CcSEcCtD
Docetaxel—Hypertension—Doxorubicin—prostate cancer	3.68e-06	9.16e-05	CcSEcCtD
Docetaxel—Tachycardia—Epirubicin—prostate cancer	3.67e-06	9.13e-05	CcSEcCtD
Docetaxel—Skin disorder—Epirubicin—prostate cancer	3.65e-06	9.09e-05	CcSEcCtD
Docetaxel—Chest pain—Doxorubicin—prostate cancer	3.63e-06	9.03e-05	CcSEcCtD
Docetaxel—Myalgia—Doxorubicin—prostate cancer	3.63e-06	9.03e-05	CcSEcCtD
Docetaxel—Arthralgia—Doxorubicin—prostate cancer	3.63e-06	9.03e-05	CcSEcCtD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	3.6e-06	8.97e-05	CcSEcCtD
Docetaxel—Anorexia—Epirubicin—prostate cancer	3.58e-06	8.92e-05	CcSEcCtD
Docetaxel—Dizziness—Capecitabine—prostate cancer	3.56e-06	8.88e-05	CcSEcCtD
Docetaxel—Dry mouth—Doxorubicin—prostate cancer	3.55e-06	8.83e-05	CcSEcCtD
Docetaxel—Hypersensitivity—Prednisone—prostate cancer	3.54e-06	8.82e-05	CcSEcCtD
Docetaxel—Hypotension—Epirubicin—prostate cancer	3.51e-06	8.74e-05	CcSEcCtD
Docetaxel—Confusional state—Doxorubicin—prostate cancer	3.5e-06	8.73e-05	CcSEcCtD
Docetaxel—Oedema—Doxorubicin—prostate cancer	3.48e-06	8.66e-05	CcSEcCtD
Docetaxel—Anaphylactic shock—Doxorubicin—prostate cancer	3.48e-06	8.66e-05	CcSEcCtD
Docetaxel—Infection—Doxorubicin—prostate cancer	3.45e-06	8.6e-05	CcSEcCtD
Docetaxel—Asthenia—Prednisone—prostate cancer	3.45e-06	8.59e-05	CcSEcCtD
Docetaxel—Vomiting—Capecitabine—prostate cancer	3.43e-06	8.54e-05	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Epirubicin—prostate cancer	3.42e-06	8.53e-05	CcSEcCtD
Docetaxel—Shock—Doxorubicin—prostate cancer	3.42e-06	8.52e-05	CcSEcCtD
Docetaxel—Nervous system disorder—Doxorubicin—prostate cancer	3.41e-06	8.49e-05	CcSEcCtD
Docetaxel—Thrombocytopenia—Doxorubicin—prostate cancer	3.4e-06	8.48e-05	CcSEcCtD
Docetaxel—Rash—Capecitabine—prostate cancer	3.4e-06	8.47e-05	CcSEcCtD
Docetaxel—Pruritus—Prednisone—prostate cancer	3.4e-06	8.47e-05	CcSEcCtD
Docetaxel—Insomnia—Epirubicin—prostate cancer	3.4e-06	8.46e-05	CcSEcCtD
Docetaxel—Dermatitis—Capecitabine—prostate cancer	3.4e-06	8.46e-05	CcSEcCtD
Docetaxel—Tachycardia—Doxorubicin—prostate cancer	3.39e-06	8.45e-05	CcSEcCtD
Docetaxel—Headache—Capecitabine—prostate cancer	3.38e-06	8.42e-05	CcSEcCtD
Docetaxel—Skin disorder—Doxorubicin—prostate cancer	3.38e-06	8.41e-05	CcSEcCtD
Docetaxel—Paraesthesia—Epirubicin—prostate cancer	3.37e-06	8.4e-05	CcSEcCtD
Docetaxel—Dyspnoea—Epirubicin—prostate cancer	3.35e-06	8.34e-05	CcSEcCtD
Docetaxel—Somnolence—Epirubicin—prostate cancer	3.34e-06	8.32e-05	CcSEcCtD
Docetaxel—Anorexia—Doxorubicin—prostate cancer	3.31e-06	8.25e-05	CcSEcCtD
Docetaxel—Dyspepsia—Epirubicin—prostate cancer	3.31e-06	8.24e-05	CcSEcCtD
Docetaxel—Diarrhoea—Prednisone—prostate cancer	3.29e-06	8.19e-05	CcSEcCtD
Docetaxel—Decreased appetite—Epirubicin—prostate cancer	3.26e-06	8.14e-05	CcSEcCtD
Docetaxel—Hypotension—Doxorubicin—prostate cancer	3.25e-06	8.09e-05	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Epirubicin—prostate cancer	3.24e-06	8.08e-05	CcSEcCtD
Docetaxel—Fatigue—Epirubicin—prostate cancer	3.24e-06	8.07e-05	CcSEcCtD
Docetaxel—Pain—Epirubicin—prostate cancer	3.21e-06	8e-05	CcSEcCtD
Docetaxel—Constipation—Epirubicin—prostate cancer	3.21e-06	8e-05	CcSEcCtD
Docetaxel—Nausea—Capecitabine—prostate cancer	3.2e-06	7.98e-05	CcSEcCtD
Docetaxel—Dizziness—Prednisone—prostate cancer	3.18e-06	7.91e-05	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Doxorubicin—prostate cancer	3.17e-06	7.89e-05	CcSEcCtD
Docetaxel—Insomnia—Doxorubicin—prostate cancer	3.14e-06	7.83e-05	CcSEcCtD
Docetaxel—Paraesthesia—Doxorubicin—prostate cancer	3.12e-06	7.78e-05	CcSEcCtD
Docetaxel—Dyspnoea—Doxorubicin—prostate cancer	3.1e-06	7.72e-05	CcSEcCtD
Docetaxel—Feeling abnormal—Epirubicin—prostate cancer	3.09e-06	7.71e-05	CcSEcCtD
Docetaxel—Somnolence—Doxorubicin—prostate cancer	3.09e-06	7.7e-05	CcSEcCtD
Docetaxel—Gastrointestinal pain—Epirubicin—prostate cancer	3.07e-06	7.65e-05	CcSEcCtD
Docetaxel—Dyspepsia—Doxorubicin—prostate cancer	3.06e-06	7.62e-05	CcSEcCtD
Docetaxel—Vomiting—Prednisone—prostate cancer	3.05e-06	7.61e-05	CcSEcCtD
Docetaxel—Rash—Prednisone—prostate cancer	3.03e-06	7.54e-05	CcSEcCtD
Docetaxel—Dermatitis—Prednisone—prostate cancer	3.02e-06	7.54e-05	CcSEcCtD
Docetaxel—Decreased appetite—Doxorubicin—prostate cancer	3.02e-06	7.53e-05	CcSEcCtD
Docetaxel—Headache—Prednisone—prostate cancer	3.01e-06	7.5e-05	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Doxorubicin—prostate cancer	3e-06	7.48e-05	CcSEcCtD
Docetaxel—Fatigue—Doxorubicin—prostate cancer	3e-06	7.47e-05	CcSEcCtD
Docetaxel—Constipation—Doxorubicin—prostate cancer	2.97e-06	7.4e-05	CcSEcCtD
Docetaxel—Pain—Doxorubicin—prostate cancer	2.97e-06	7.4e-05	CcSEcCtD
Docetaxel—Body temperature increased—Epirubicin—prostate cancer	2.97e-06	7.4e-05	CcSEcCtD
Docetaxel—Abdominal pain—Epirubicin—prostate cancer	2.97e-06	7.4e-05	CcSEcCtD
Docetaxel—Feeling abnormal—Doxorubicin—prostate cancer	2.86e-06	7.14e-05	CcSEcCtD
Docetaxel—Nausea—Prednisone—prostate cancer	2.85e-06	7.11e-05	CcSEcCtD
Docetaxel—Gastrointestinal pain—Doxorubicin—prostate cancer	2.84e-06	7.08e-05	CcSEcCtD
Docetaxel—Hypersensitivity—Epirubicin—prostate cancer	2.77e-06	6.89e-05	CcSEcCtD
Docetaxel—Abdominal pain—Doxorubicin—prostate cancer	2.75e-06	6.85e-05	CcSEcCtD
Docetaxel—Body temperature increased—Doxorubicin—prostate cancer	2.75e-06	6.85e-05	CcSEcCtD
Docetaxel—Asthenia—Epirubicin—prostate cancer	2.69e-06	6.71e-05	CcSEcCtD
Docetaxel—Pruritus—Epirubicin—prostate cancer	2.66e-06	6.62e-05	CcSEcCtD
Docetaxel—Diarrhoea—Epirubicin—prostate cancer	2.57e-06	6.4e-05	CcSEcCtD
Docetaxel—Hypersensitivity—Doxorubicin—prostate cancer	2.56e-06	6.38e-05	CcSEcCtD
Docetaxel—Asthenia—Doxorubicin—prostate cancer	2.49e-06	6.21e-05	CcSEcCtD
Docetaxel—Dizziness—Epirubicin—prostate cancer	2.48e-06	6.19e-05	CcSEcCtD
Docetaxel—Pruritus—Doxorubicin—prostate cancer	2.46e-06	6.13e-05	CcSEcCtD
Docetaxel—Vomiting—Epirubicin—prostate cancer	2.39e-06	5.95e-05	CcSEcCtD
Docetaxel—Diarrhoea—Doxorubicin—prostate cancer	2.38e-06	5.92e-05	CcSEcCtD
Docetaxel—Rash—Epirubicin—prostate cancer	2.37e-06	5.9e-05	CcSEcCtD
Docetaxel—Dermatitis—Epirubicin—prostate cancer	2.37e-06	5.9e-05	CcSEcCtD
Docetaxel—Headache—Epirubicin—prostate cancer	2.35e-06	5.86e-05	CcSEcCtD
Docetaxel—Dizziness—Doxorubicin—prostate cancer	2.3e-06	5.73e-05	CcSEcCtD
Docetaxel—Nausea—Epirubicin—prostate cancer	2.23e-06	5.56e-05	CcSEcCtD
Docetaxel—Vomiting—Doxorubicin—prostate cancer	2.21e-06	5.51e-05	CcSEcCtD
Docetaxel—Rash—Doxorubicin—prostate cancer	2.19e-06	5.46e-05	CcSEcCtD
Docetaxel—Dermatitis—Doxorubicin—prostate cancer	2.19e-06	5.45e-05	CcSEcCtD
Docetaxel—Headache—Doxorubicin—prostate cancer	2.18e-06	5.42e-05	CcSEcCtD
Docetaxel—Nausea—Doxorubicin—prostate cancer	2.06e-06	5.14e-05	CcSEcCtD
Docetaxel—ABCC1—Disease—PTGS2—prostate cancer	2.85e-07	9.25e-06	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—AKT1—prostate cancer	2.84e-07	9.23e-06	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—CREBBP—prostate cancer	2.82e-07	9.15e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—SLC22A3—prostate cancer	2.82e-07	9.15e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—HSD3B1—prostate cancer	2.82e-07	9.15e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—HIF1A—prostate cancer	2.81e-07	9.13e-06	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—EP300—prostate cancer	2.8e-07	9.12e-06	CbGpPWpGaD
Docetaxel—EGFR—Disease—MDM2—prostate cancer	2.78e-07	9.05e-06	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PIK3CG—prostate cancer	2.76e-07	8.98e-06	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PIK3CD—prostate cancer	2.76e-07	8.97e-06	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CDKN1B—prostate cancer	2.75e-07	8.95e-06	CbGpPWpGaD
Docetaxel—EGFR—Disease—ERBB2—prostate cancer	2.74e-07	8.92e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—LEP—prostate cancer	2.74e-07	8.91e-06	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PIK3CG—prostate cancer	2.74e-07	8.9e-06	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—IL6—prostate cancer	2.72e-07	8.84e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—SLC5A5—prostate cancer	2.72e-07	8.84e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CAV1—prostate cancer	2.72e-07	8.83e-06	CbGpPWpGaD
Docetaxel—EGFR—Disease—PIK3CB—prostate cancer	2.71e-07	8.8e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—TBXAS1—prostate cancer	2.7e-07	8.78e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GSTA4—prostate cancer	2.7e-07	8.78e-06	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—TYMS—prostate cancer	2.7e-07	8.77e-06	CbGpPWpGaD
Docetaxel—ABCC1—Disease—CDKN1B—prostate cancer	2.7e-07	8.76e-06	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IL2—prostate cancer	2.69e-07	8.76e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—KDR—prostate cancer	2.69e-07	8.73e-06	CbGpPWpGaD
Docetaxel—EGFR—Disease—PTGS2—prostate cancer	2.68e-07	8.72e-06	CbGpPWpGaD
Docetaxel—BCL2—Immune System—IL6—prostate cancer	2.68e-07	8.71e-06	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PIK3CD—prostate cancer	2.67e-07	8.68e-06	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—GSTM1—prostate cancer	2.67e-07	8.67e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CYP2E1—prostate cancer	2.65e-07	8.63e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GSTA2—prostate cancer	2.63e-07	8.55e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—NQO1—prostate cancer	2.63e-07	8.53e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—ESR1—prostate cancer	2.62e-07	8.51e-06	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—LPL—prostate cancer	2.62e-07	8.51e-06	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—INS—prostate cancer	2.62e-07	8.5e-06	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—NOS3—prostate cancer	2.61e-07	8.47e-06	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CTNNB1—prostate cancer	2.6e-07	8.45e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ABCG5—prostate cancer	2.6e-07	8.45e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—SULT1A1—prostate cancer	2.6e-07	8.45e-06	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—INS—prostate cancer	2.59e-07	8.43e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—TH—prostate cancer	2.59e-07	8.41e-06	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—CREBBP—prostate cancer	2.56e-07	8.33e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CYP3A4—prostate cancer	2.56e-07	8.32e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—BAD—prostate cancer	2.56e-07	8.31e-06	CbGpPWpGaD
Docetaxel—ABCC1—Disease—CTNNB1—prostate cancer	2.55e-07	8.28e-06	CbGpPWpGaD
Docetaxel—EGFR—Disease—CDKN1B—prostate cancer	2.54e-07	8.26e-06	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CDKN1A—prostate cancer	2.54e-07	8.26e-06	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—CREBBP—prostate cancer	2.54e-07	8.25e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GSTA1—prostate cancer	2.54e-07	8.25e-06	CbGpPWpGaD
Docetaxel—EGFR—Immune System—PTEN—prostate cancer	2.53e-07	8.24e-06	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—CYP1A1—prostate cancer	2.53e-07	8.22e-06	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—NOS3—prostate cancer	2.52e-07	8.2e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CYP1B1—prostate cancer	2.52e-07	8.18e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GSTO1—prostate cancer	2.51e-07	8.16e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—HSD3B2—prostate cancer	2.51e-07	8.16e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—NAT2—prostate cancer	2.51e-07	8.16e-06	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—AKT1—prostate cancer	2.51e-07	8.15e-06	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—ERCC2—prostate cancer	2.51e-07	8.15e-06	CbGpPWpGaD
Docetaxel—ABCC1—Disease—CDKN1A—prostate cancer	2.49e-07	8.09e-06	CbGpPWpGaD
Docetaxel—ABCC1—Disease—PTEN—prostate cancer	2.48e-07	8.07e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PIK3CG—prostate cancer	2.48e-07	8.04e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—APC—prostate cancer	2.48e-07	8.04e-06	CbGpPWpGaD
Docetaxel—BCL2—Immune System—AKT1—prostate cancer	2.47e-07	8.03e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—IRS1—prostate cancer	2.45e-07	7.95e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—EGF—prostate cancer	2.45e-07	7.95e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—GGT1—prostate cancer	2.44e-07	7.92e-06	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PIK3CD—prostate cancer	2.43e-07	7.9e-06	CbGpPWpGaD
Docetaxel—EGFR—Immune System—EP300—prostate cancer	2.42e-07	7.86e-06	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—AKT1—prostate cancer	2.41e-07	7.83e-06	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PIK3CD—prostate cancer	2.41e-07	7.83e-06	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PIK3CB—prostate cancer	2.41e-07	7.82e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PLCB2—prostate cancer	2.41e-07	7.82e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CYP2C18—prostate cancer	2.41e-07	7.82e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—LRP2—prostate cancer	2.41e-07	7.82e-06	CbGpPWpGaD
Docetaxel—EGFR—Disease—CTNNB1—prostate cancer	2.4e-07	7.8e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—NCOA1—prostate cancer	2.4e-07	7.8e-06	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PTGS2—prostate cancer	2.38e-07	7.75e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—GSK3B—prostate cancer	2.38e-07	7.72e-06	CbGpPWpGaD
Docetaxel—ABCC1—Disease—EP300—prostate cancer	2.37e-07	7.7e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CYP19A1—prostate cancer	2.37e-07	7.69e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—P4HB—prostate cancer	2.36e-07	7.67e-06	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—MTHFR—prostate cancer	2.36e-07	7.66e-06	CbGpPWpGaD
Docetaxel—EGFR—Immune System—SRC—prostate cancer	2.35e-07	7.64e-06	CbGpPWpGaD
Docetaxel—EGFR—Disease—CDKN1A—prostate cancer	2.35e-07	7.62e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—INS—prostate cancer	2.34e-07	7.62e-06	CbGpPWpGaD
Docetaxel—EGFR—Disease—PTEN—prostate cancer	2.34e-07	7.61e-06	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PIK3CB—prostate cancer	2.33e-07	7.56e-06	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PPARA—prostate cancer	2.31e-07	7.51e-06	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PTGS2—prostate cancer	2.31e-07	7.5e-06	CbGpPWpGaD
Docetaxel—ABCC1—Disease—SRC—prostate cancer	2.3e-07	7.48e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—SLC22A1—prostate cancer	2.3e-07	7.46e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CREBBP—prostate cancer	2.29e-07	7.46e-06	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—NOS3—prostate cancer	2.29e-07	7.46e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—RXRA—prostate cancer	2.28e-07	7.42e-06	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—NOS3—prostate cancer	2.27e-07	7.39e-06	CbGpPWpGaD
Docetaxel—EGFR—Immune System—STAT3—prostate cancer	2.27e-07	7.37e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—IGF1—prostate cancer	2.27e-07	7.37e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—SULT2A1—prostate cancer	2.24e-07	7.27e-06	CbGpPWpGaD
Docetaxel—EGFR—Disease—EP300—prostate cancer	2.23e-07	7.25e-06	CbGpPWpGaD
Docetaxel—ABCC1—Disease—STAT3—prostate cancer	2.22e-07	7.22e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—MED12—prostate cancer	2.2e-07	7.15e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—COMT—prostate cancer	2.2e-07	7.15e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MAP2K1—prostate cancer	2.19e-07	7.12e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—GSTP1—prostate cancer	2.19e-07	7.12e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GNG5—prostate cancer	2.18e-07	7.1e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PIK3CD—prostate cancer	2.18e-07	7.07e-06	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—CAV1—prostate cancer	2.17e-07	7.07e-06	CbGpPWpGaD
Docetaxel—EGFR—Disease—SRC—prostate cancer	2.17e-07	7.05e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—ITPR1—prostate cancer	2.15e-07	7e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—SERPINE1—prostate cancer	2.15e-07	6.99e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—KRAS—prostate cancer	2.13e-07	6.92e-06	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PIK3CB—prostate cancer	2.12e-07	6.88e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—NCOA3—prostate cancer	2.1e-07	6.84e-06	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PIK3CB—prostate cancer	2.1e-07	6.82e-06	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PTGS2—prostate cancer	2.1e-07	6.82e-06	CbGpPWpGaD
Docetaxel—EGFR—Disease—STAT3—prostate cancer	2.09e-07	6.8e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—FGF2—prostate cancer	2.08e-07	6.77e-06	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PTGS2—prostate cancer	2.08e-07	6.76e-06	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PTEN—prostate cancer	2.08e-07	6.76e-06	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—PIK3CA—prostate cancer	2.07e-07	6.74e-06	CbGpPWpGaD
Docetaxel—ABCC1—Disease—MYC—prostate cancer	2.06e-07	6.71e-06	CbGpPWpGaD
Docetaxel—ABCC1—Disease—TGFB1—prostate cancer	2.06e-07	6.69e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—NOS3—prostate cancer	2.05e-07	6.68e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—TYMS—prostate cancer	2.04e-07	6.62e-06	CbGpPWpGaD
Docetaxel—ABCC1—Disease—EGFR—prostate cancer	2.02e-07	6.56e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—GSTM1—prostate cancer	2.01e-07	6.54e-06	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PTEN—prostate cancer	2.01e-07	6.54e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—HPGDS—prostate cancer	2.01e-07	6.52e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—JAK2—prostate cancer	2e-07	6.49e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CYP2C19—prostate cancer	1.99e-07	6.48e-06	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—EP300—prostate cancer	1.98e-07	6.45e-06	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PIK3CG—prostate cancer	1.98e-07	6.44e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—LPL—prostate cancer	1.97e-07	6.42e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—PIK3CA—prostate cancer	1.96e-07	6.36e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MDM2—prostate cancer	1.95e-07	6.34e-06	CbGpPWpGaD
Docetaxel—EGFR—Immune System—KRAS—prostate cancer	1.95e-07	6.33e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ACHE—prostate cancer	1.95e-07	6.33e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GSTT1—prostate cancer	1.95e-07	6.33e-06	CbGpPWpGaD
Docetaxel—EGFR—Disease—MYC—prostate cancer	1.94e-07	6.32e-06	CbGpPWpGaD
Docetaxel—EGFR—Disease—TGFB1—prostate cancer	1.94e-07	6.31e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CYP2A6—prostate cancer	1.92e-07	6.25e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—ERBB2—prostate cancer	1.92e-07	6.25e-06	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—EP300—prostate cancer	1.92e-07	6.23e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CYP1A1—prostate cancer	1.91e-07	6.2e-06	CbGpPWpGaD
Docetaxel—ABCC1—Disease—KRAS—prostate cancer	1.91e-07	6.2e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PIK3CB—prostate cancer	1.9e-07	6.16e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—ERCC2—prostate cancer	1.89e-07	6.15e-06	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—INS—prostate cancer	1.87e-07	6.09e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—AKR1C3—prostate cancer	1.87e-07	6.08e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PRKACB—prostate cancer	1.86e-07	6.05e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CYP17A1—prostate cancer	1.84e-07	5.99e-06	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—CREBBP—prostate cancer	1.84e-07	5.97e-06	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PTEN—prostate cancer	1.83e-07	5.95e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CXCL8—prostate cancer	1.82e-07	5.92e-06	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PTEN—prostate cancer	1.81e-07	5.89e-06	CbGpPWpGaD
Docetaxel—EGFR—Disease—KRAS—prostate cancer	1.8e-07	5.84e-06	CbGpPWpGaD
Docetaxel—EGFR—Immune System—PIK3CA—prostate cancer	1.79e-07	5.81e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CDKN1B—prostate cancer	1.78e-07	5.79e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—MTHFR—prostate cancer	1.78e-07	5.78e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—NCOA2—prostate cancer	1.76e-07	5.71e-06	CbGpPWpGaD
Docetaxel—ABCC1—Disease—PIK3CA—prostate cancer	1.75e-07	5.69e-06	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—EP300—prostate cancer	1.74e-07	5.67e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PPARA—prostate cancer	1.74e-07	5.67e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CASP3—prostate cancer	1.74e-07	5.67e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—IL2—prostate cancer	1.74e-07	5.66e-06	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PIK3CD—prostate cancer	1.74e-07	5.66e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—IL6—prostate cancer	1.73e-07	5.63e-06	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—EP300—prostate cancer	1.73e-07	5.62e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CCND1—prostate cancer	1.7e-07	5.52e-06	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—AKT1—prostate cancer	1.69e-07	5.51e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CTNNB1—prostate cancer	1.68e-07	5.47e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—SLC5A5—prostate cancer	1.67e-07	5.44e-06	CbGpPWpGaD
Docetaxel—EGFR—Disease—PIK3CA—prostate cancer	1.65e-07	5.37e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MMP9—prostate cancer	1.65e-07	5.36e-06	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—NOS3—prostate cancer	1.64e-07	5.34e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CDKN1A—prostate cancer	1.64e-07	5.34e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CAV1—prostate cancer	1.64e-07	5.33e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PTEN—prostate cancer	1.64e-07	5.33e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CYP2E1—prostate cancer	1.64e-07	5.32e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—NQO1—prostate cancer	1.62e-07	5.26e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—AKT1—prostate cancer	1.6e-07	5.2e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—TH—prostate cancer	1.59e-07	5.18e-06	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IL6—prostate cancer	1.58e-07	5.15e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—EP300—prostate cancer	1.56e-07	5.08e-06	CbGpPWpGaD
Docetaxel—ABCC1—Disease—IL6—prostate cancer	1.55e-07	5.04e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CYP1B1—prostate cancer	1.55e-07	5.04e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—SRC—prostate cancer	1.52e-07	4.94e-06	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PIK3CB—prostate cancer	1.52e-07	4.93e-06	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PTGS2—prostate cancer	1.5e-07	4.89e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GGT1—prostate cancer	1.5e-07	4.88e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PIK3CG—prostate cancer	1.49e-07	4.86e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—VEGFA—prostate cancer	1.48e-07	4.81e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—NCOA1—prostate cancer	1.48e-07	4.81e-06	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PIK3CA—prostate cancer	1.47e-07	4.77e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—STAT3—prostate cancer	1.47e-07	4.76e-06	CbGpPWpGaD
Docetaxel—EGFR—Disease—IL6—prostate cancer	1.46e-07	4.75e-06	CbGpPWpGaD
Docetaxel—EGFR—Immune System—AKT1—prostate cancer	1.46e-07	4.75e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CYP19A1—prostate cancer	1.46e-07	4.74e-06	CbGpPWpGaD
Docetaxel—ABCC1—Disease—AKT1—prostate cancer	1.43e-07	4.65e-06	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PIK3CA—prostate cancer	1.42e-07	4.61e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—INS—prostate cancer	1.41e-07	4.6e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—RXRA—prostate cancer	1.41e-07	4.57e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CREBBP—prostate cancer	1.39e-07	4.5e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MYC—prostate cancer	1.36e-07	4.43e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TGFB1—prostate cancer	1.36e-07	4.42e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—COMT—prostate cancer	1.36e-07	4.41e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GSTP1—prostate cancer	1.35e-07	4.38e-06	CbGpPWpGaD
Docetaxel—EGFR—Disease—AKT1—prostate cancer	1.35e-07	4.38e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ITPR1—prostate cancer	1.33e-07	4.31e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PIK3CD—prostate cancer	1.31e-07	4.27e-06	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PTEN—prostate cancer	1.31e-07	4.26e-06	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PIK3CA—prostate cancer	1.29e-07	4.2e-06	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PIK3CA—prostate cancer	1.28e-07	4.16e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—KRAS—prostate cancer	1.26e-07	4.09e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—TYMS—prostate cancer	1.25e-07	4.08e-06	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—EP300—prostate cancer	1.25e-07	4.06e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—NOS3—prostate cancer	1.24e-07	4.03e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GSTM1—prostate cancer	1.24e-07	4.03e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—LPL—prostate cancer	1.22e-07	3.96e-06	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—AKT1—prostate cancer	1.2e-07	3.9e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CYP1A1—prostate cancer	1.18e-07	3.82e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ERCC2—prostate cancer	1.17e-07	3.79e-06	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—AKT1—prostate cancer	1.16e-07	3.77e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PIK3CA—prostate cancer	1.16e-07	3.76e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PIK3CB—prostate cancer	1.14e-07	3.72e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PTGS2—prostate cancer	1.13e-07	3.69e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TP53—prostate cancer	1.12e-07	3.64e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—MTHFR—prostate cancer	1.1e-07	3.56e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PPARA—prostate cancer	1.07e-07	3.49e-06	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—AKT1—prostate cancer	1.05e-07	3.43e-06	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—AKT1—prostate cancer	1.05e-07	3.4e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—IL6—prostate cancer	1.02e-07	3.33e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CAV1—prostate cancer	1.01e-07	3.28e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PTEN—prostate cancer	9.89e-08	3.22e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—AKT1—prostate cancer	9.44e-08	3.07e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—EP300—prostate cancer	9.43e-08	3.07e-06	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PIK3CA—prostate cancer	9.25e-08	3.01e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PIK3CG—prostate cancer	9.2e-08	2.99e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—INS—prostate cancer	8.71e-08	2.83e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CREBBP—prostate cancer	8.53e-08	2.77e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PIK3CD—prostate cancer	8.09e-08	2.63e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—NOS3—prostate cancer	7.64e-08	2.48e-06	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—AKT1—prostate cancer	7.56e-08	2.46e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PIK3CB—prostate cancer	7.05e-08	2.29e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PTGS2—prostate cancer	6.99e-08	2.27e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PIK3CA—prostate cancer	6.98e-08	2.27e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PTEN—prostate cancer	6.09e-08	1.98e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—EP300—prostate cancer	5.81e-08	1.89e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—AKT1—prostate cancer	5.7e-08	1.85e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PIK3CA—prostate cancer	4.3e-08	1.4e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—AKT1—prostate cancer	3.51e-08	1.14e-06	CbGpPWpGaD
